Ligand Pharmaceuticals
LGND
#2805
Rank
A$8.61 B
Marketcap
A$431.92
Share price
2.31%
Change (1 day)
57.34%
Change (1 year)

Ligand Pharmaceuticals (LGND) - Net assets

Net assets on the balance sheet as of June 2026 : A$1.38 Billion

According to Ligand Pharmaceuticals's latest financial reports the company has A$1.38 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Ligand Pharmaceuticals - Net assets on balance sheet (from 2001 to 2026)

Net assets by year

Year Net assets Change
2025-12-31$A$1.51 B13.75%
2024-12-31$A$1.33 B29.78%
2023-12-31$A$1.02 B17.17%
2022-12-31$A$0.87 B-22.48%
2021-12-31$A$1.13 B22.75%
2020-12-31$A$0.92 B-15.79%
2019-12-31$A$1.09 B37.63%
2018-12-31$A$0.79 B48.48%
2017-12-31$A$0.53 B4.23%
2016-12-31$A$0.51 B35.35%
2015-12-31$A$0.38 B1174.52%
2014-12-31$A$29.82 M-46.38%
2013-12-31$A$55.62 M118.24%
2012-12-31$A$25.48 M219.27%
2011-12-31$A$7.98 M-267.22%
2010-12-31$-A$4.78 Million-214.54%
2009-12-31$A$4.16 M-128.37%
2008-12-31$-A$14.7 Million-144.12%
2007-12-31$A$33.3 M-4.02%
2006-12-31$A$34.69 M-122.99%
2005-12-31$-A$0.16 Billion55.05%
2004-12-31$-A$97.33 Million92.64%
2003-12-31$-A$50.53 Million-138.46%
2002-12-31$A$0.13 B-215.85%
2001-12-31$-A$0.12 Billion

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Johnson & Johnson
JNJ
A$121.60 B 8,682.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
A$122.34 B 8,736.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$48.48 B 3,401.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$16.72 B 1,108.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
A$8.84 B 538.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$60.08 B 4,239.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$31.94 B 2,206.84%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
A$32.57 B 2,252.48%๐Ÿ‡ฌ๐Ÿ‡ง UK
Spectrum Pharmaceuticals
SPPI
A$38.36 M-97.23%๐Ÿ‡บ๐Ÿ‡ธ USA